Medtronic beats profit estimates on strong demand for heart devices
In this article:
Feb 20 (Reuters) - Medtronic beat Wall Street estimates for third-quarter profit on Tuesday, aided by strong demand for its heart and diabetes devices.
The company added that it decided to exit its ventilator product line, and retain and combine the remaining PMRI businesses into one business unit.
Medtronic posted an adjusted profit of $1.30 per share for the quarter, compared with analysts' estimates of $1.26 per share, according to LSEG data. (Reporting by Christy Santhosh and Vaibhav Sadhamta in Bengaluru; Editing by Shounak Dasgupta and Shilpi Majumdar)
